Board of Directors
- Jean-Claude LAVOREL
Position : Chairman and Chief Executive Officer
End of Mandate: March 2017 (or Ordinary General Meeting - Financial year ended September 30th, 2016)
An entrepreneur, between 1976-1983 Jean-Claude LAVOREL was responsible for sales and marketing within the Synthelabo Group, which specialised in medical equipment, before its merger with the German group Hellige, specialising in electronic medical equipment. Mr LAVOREL was then director of sales and marketing up to 1989.
- Stanislas LAVOREL
Position : Director and Deputy Chief Executive Officer
End of Mandate: March 2017 (or Ordinary General Meeting - Financial year ended September 30th, 2016)
Holder of a Post-Graduate Diploma (DESS) in finance and banking law, Stanislas LAVOREL was initially a consultant before joining LVL Medical where he is now Deputy Chief Executive Officer. Since 2007 he has also been a judge with Lyon’s Tribunal de Commerce (Commercial Court).
- Benjamin LAVOREL
Position : Director
End of Mandate: March 2012 (or Ordinary General Meeting - Financial year ended September 30th, 2011)
Holder of a Diploma in Management. In 1997, after studying with l’Ecole de Management de Lyon (EM Lyon), Benjamin LAVOREL became manager of PRIS, (Institut français de Collecte pour la Prévention des Risques). This business, based in Villeurbanne, specialises in environmental management (collection of medical waste). Since 2000, Benjamin LAVOREL has been managing director of a number of businesses.
- Jacques MIGNOT
Position : Director
End of Mandate: march 2014 (or Ordinary General Meeting - Financial year ended September 30th, 2013)
Holder of a Master’s in Economics, followed by a CESMA MBA and a CPA Executive MBA from HEC, Jacques MIGNOT brings solid experience of business management, particularly with Group OCP (Celesio). From 1983 to 1986, he was successively managing director, then (from 1990 to 1997) Chairman of ODS, Orkyn, and DGX Pharma ; of Fininvest (from 1997 to 2003) and since 2003, Chairman of Neftys Pharma, Elvetis and Véto Santé.
- Jean-Pierre CLAVERANNE
Position : Director
End of Mandate: March 2016 (or Ordinary General Meeting - Financial year ended September 30th, 2015)
Graduate in Economics from the Paris 1 University, and a former student of the Ecole Normale Supérieure de Cachan, Mr. CLAVERANNE holds a PhD in Management and is an Aggregate of economics and management. A professor at the Faculty of Law at Jean Moulin University, he also advises large international organisations.
- MALAKOFF MEDERIC ASSURANCES
Represented by Mme Isabelle HEBERT
Position : Director
End of Mandate: March 2016 (or Ordinary General Meeting - Financial year ended September 30th, 2015)
Markets health and foresight Director for the Malakoff Mederic Group.
Trained in economics and holder of a Diploma from the Ecole Nationale de la Statistique et de l'Administration Economique, Isabelle HEBERT is a former student of the Ecole Normale Supérieure de Cachan. For 12 years she practiced internationally in the health insurance sector. In particular, she worked in the United States with two of the four large private health insurance companies.
- MALAKOFF MEDERIC PREVOYANCE
Represented by Mr Hugues de MOLLERAT du JEU
Position : Director
End of Mandate: March 2016 (or Ordinary General Meeting - Financial year ended September 30th, 2015)
Strategy and Marketing Director for the Malakoff Médéric Group, Mr. MOLLERAT DU JEU held several management posts within the Médéric Group before managing the Malakoff-Médéric merger.
Version française
